Does oral administration of Dictyostelium differentiation-inducing factor 1 lower blood glucose levels in streptozotocin-induced diabetic rats?
These results indicate that DIF-1 may be a good lead compound for the development of anti-diabetic drugs.
The overall quality of reporting of surgical RCTs was suboptimal. There is a need for improving awareness of the CONSORT statement among authors, reviewers, and editors of surgical journals and better quality control measures for trial reporting and methodology.